绝经激素治疗联合定坤丹在围绝经期综合征中的应用

Abstract
Figure/Table
References (20)
Related Citation (15)

Download: PDF (593 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the application effect of Estradiol/Estradiol-Dydrogesterone Tablets combined with Dingkundan in perimenopausal syndrome. Methods A total of 30 patients with perimenopausal syndrome who were admitted to Jiangxi Maternal and Child Health Hospital from January to December 2020 were selected as the research objects, and they were divided into the control group and the observation group by random number table method, 15 cases in each group. The control group received Estradiol/Estradiol-Dydrogesterone Tablet treatment, and the observation group received Dingkundan treatment on the basis of the control group. The degree of symptom improvement, coagulation function, quality of life and the incidence of adverse reactions were compared between the two groups. Results There were no significant differences in the scores of modified Kupperman menopausal index (KMI), coagulation function index and the scores of quality of life index between the two groups before treatment(P>0.05).The KMI score of patients in the observation group after treatment was lower than that of the control group, and the difference was statistically significant (P<0.05).After treatment,the levels of prothrombin time(PT)and partial prothrombin time(APTT)of the observation group were shorter than those of the control group, the levels of original (FIB) and D-Ⅱpolymer (D-Ⅱ) of the observation group were lower than those of the control group, and the level of antithrombin Ⅲ (AT-Ⅲ) of the observation group was higher than that of the control group, and the differences were statistically significant (P<0.05). There was no significant difference in thrombin time (TT) after treatment between the two groups (P>0.05). After treatment, the quality of life score of the observation group was higher than that of the control group, and the difference was statistically significant (P<0.05). The incidence of breast tenderness in the observation group was 26.67%, which was lower than that in the control group (86.67%), and the difference was statistically significant (P<0.05). Conclusion Patients with perimenopausal syndrome receiving Estradiol/Estradiol-Dydrogesterone Tablets combined with Dingkundan therapy can better improve symptoms, reduce the adverse effects on coagulation function, and improve the quality of life of patients.

Key words： Perimenopausal syndrome Estradiol/Estradiol Dydrogesterone Tablets Dingkundan Coagulation function;Quality of life Adverse reaction

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI Lijun
	CHEN Xuemei
	LUO Suqin
	LIU Wei
	XIONG Jieqi
	XIE Xiaohua
	YANG Huimin

Cite this article:

LI Lijun,CHEN Xuemei,LUO Suqin, et al. Application of menopausal hormone therapy combined with Dingkundan in perimenopausal syndrome[J]. 中国当代医药, 2022, 29(24): 69-72.

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2022/V29/I24/69

[1]	璩丽燕，祝萍，周剑.定坤丹联合戊酸雌二醇对围绝经综合征妇女激素水平和心理状态的影响[J].当代医学，2020，26（20）：10-12.
[2]	李海燕，邱巍峰，徐玉萍，等.定坤丹对女性更年期症状的疗效评价[J].河北医药，2018，40（23）：3610-3612.
[3]	高敬棉.定坤丹联合克龄蒙在更年期妇女保健中的疗效分析[J].实用妇科内分泌电子杂志，2019，6（32）：37，47.
[4]	李亚荣，何卫宁.定坤丹、激素及激素合并定坤丹治疗围绝经期综合征的临床研究[J].贵州医药，2020，44（12）：1886-1888.
[5]	陈淑敏，董黎.定坤丹联合替勃龙治疗围绝经期综合征的临床研究[J].现代药物与临床，2020，35（9）：1886-1890.
[6]	曹泽毅.中华妇产科学[M].2 版.北京：人民卫生出版社，2004：2537.
[7]	向玉，权祥菊，杨惠林，等.定坤丹对多囊卵巢综合征患者性激素水平、胰岛素抵抗及妊娠情况的影响[J].现代生物医学进展，2020，20（3）：578-581.
[8]	Ware Jr JE.The MOS-36-item short-from health survey（SF-36）[J].Med Care，1992，30（6）：473-483.
[9]	郗轶楠，王燕，张娜，等.克龄蒙联合定坤丹对更年期综合征患者性激素及更年期症状的影响[J].中国性科学，2021，30（1）：34-36.
[10]	史彦荣.定坤丹联合克龄蒙治疗更年期综合征的效果研究[J].当代医药论丛，2019，17（11）：178-179.
[11]	赖坚.雌激素替代疗法结合滋肾疏肝方对围绝经期综合征患者临床疗效分析[J].中国医学创新，2021，18（12）：65-68.
[12]	吴萍华.定坤丹联合心理干预辅助治疗围绝经期综合征效果观察[J].中国乡村医药，2021，20（20）：40-41.
[13]	黄丽娜，舒仪琼，方朝晖，等.六味地黄丸联合小剂量雌孕激素替代疗法对围绝经期综合征患者性激素、骨密度和血脂的影响[J].现代生物医学进展，2021，21（16）：3120-3124.
[14]	王瑜.定坤丹联合拔罐疗法治疗围绝经期综合征的疗效观察[J].中国医药指南，2018，16（21）：170.
[15]	周夏伶，何伟.不同剂量激素治疗围绝经期综合征对患者激素及血脂代谢影响[J].中国计划生育学杂志，2020，28（4）：492-495，499.
[16]	邓新，任冉.激素替代治疗在围绝经期综合征患者中的应用[J].中国当代医药，2020，27（11）：126-129.
[17]	侯博.围绝经期激素替代治疗围绝经期综合征的效果观察[J].实用妇科内分泌电子杂志，2019，6（26）：51，56.
[18]	宗海芳.定坤丹治疗绝经期泌尿生殖综合征的疗效观察[J].世界最新医学信息文摘（连续型电子期刊），2019，19（89）：11-12.
[19]	杨伟伟.中西药合用治疗围绝经期综合征疗效观察[J].实用中医药杂志，2019，35（2）：199-200.
[20]	龚会.定坤丹联合戊酸雌二醇治疗46 例围绝经期综合征的短期随访研究[J].内蒙古医学杂志，2019，51（5）：582-583.